Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of BRCA2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of BRCA2 mRNA | affects expression | 16483693
|
D001554 |
Benzene |
BRCA2 gene SNP results in increased susceptibility to Benzene | increases response to substance | 16728435
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of BRCA2 mRNA | decreases expression | 20504355
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRCA2 mRNA | decreases expression | 20382639
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of BRCA2 mRNA | decreases expression | 10344722
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA2 mRNA] | decreases expression|decreases reaction | 10344722
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of BRCA2 mRNA | decreases expression | 20106945
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of BRCA2 mRNA | increases expression | 19194470
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of BRCA2 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA2 mRNA] | decreases reaction|increases expression | 17854601
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of BRCA2 mRNA | decreases expression | 10344722
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of BRCA2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BRCA2 mRNA | affects cotreatment|increases expression | 17942748
|
D005557 |
Formaldehyde |
BRCA2 gene mutant form results in increased susceptibility to Formaldehyde | increases response to substance | 18056434
|
D019833 |
Genistein |
Genistein results in increased expression of BRCA2 mRNA | increases expression | 16434996
|
D019833 |
Genistein |
Genistein results in increased expression of BRCA2 protein | increases expression | 16434996
|
D019833 |
Genistein |
[indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA2 protein | affects cotreatment|increases expression | 16434996
|
D017313 |
Fenretinide |
Fenretinide results in decreased expression of BRCA2 mRNA | decreases expression | 16570282
|
C016517 |
indole-3-carbinol |
[indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA2 protein | affects cotreatment|increases expression | 16434996
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in increased expression of BRCA2 mRNA | increases expression | 16434996
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in increased expression of BRCA2 protein | increases expression | 16434996
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of BRCA2 mRNA | increases expression | 12634122
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of BRCA2 mRNA | increases expression | 12517777
|
D015741 |
Metribolone |
Metribolone results in increased expression of BRCA2 mRNA | increases expression | 17010196
|
D009588 |
Nitrogen Mustard Compounds |
Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA2 mRNA] | decreases expression|decreases reaction | 10344722
|
D009588 |
Nitrogen Mustard Compounds |
Nitrogen Mustard Compounds results in decreased expression of BRCA2 mRNA | decreases expression | 10344722
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of BRCA2 mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of BRCA2 mRNA | affects expression | 19136022
|
C025299 |
polyphenols |
polyphenols results in decreased expression of BRCA2 mRNA | decreases expression | 16293270
|
D011794 |
Quercetin |
Quercetin results in increased expression of BRCA2 mRNA | increases expression | 15309432
|
C059514 |
resveratrol |
resveratrol affects the expression of BRCA2 mRNA | affects expression | 15748624
|
D012402 |
Rotenone |
Rotenone results in increased expression of BRCA2 mRNA | increases expression | 18191903
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of BRCA2 mRNA | increases expression | 12760830
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of BRCA2 mRNA | affects expression | 16507464
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of BRCA2 mRNA | decreases expression | 10344722
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BRCA2 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of BRCA2 mRNA | increases expression | 17942748
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of BRCA2 mRNA | increases expression | 16434996
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of BRCA2 protein | increases expression | 16434996
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of BRCA2 protein | increases expression | 16434996
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.32 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.32 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.26 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.64 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.59 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.85 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.70 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
12.70 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.70 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
12.70 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.70 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.21 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
10.21 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.21 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
22.42 | 19061943 17162532 17620307 19052882 16434500 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
22.42 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
22.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
22.42 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.40 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.60 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.26 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.50 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.69 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.15 | 11369114 17661222 14761424 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.98 | 17084956 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.78 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.18 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.76 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.76 | 17115116 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.68 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.10 | 16873680 17967414 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.12 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.89 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.89 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.49 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.58 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.93 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.40 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.99 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.27 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
8.27 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20135344 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
7.93 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
7.93 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
7.93 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
7.93 | 18628466 15634643 16264153 16935488 15939500 19526202 18695136 11325840 15136595 15567936 16096432 18234424 18382427 16115903 15993339 15668708 15994142 17983394 16322301 16595493 17426702 17369602 16826403 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
7.93 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Formaldehyde |
7.93 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
7.93 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
indole-3-carbinol |
7.93 | 16082211 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
7.93 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
7.93 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
7.93 | 20435547 |
OMIM:612555 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 |
marker/mechanism |
|
| |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.25 | 16962696 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.51 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.57 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
18.88 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
18.88 | 20007298 16878318 11831363 16807293 19822196 17428255 19701751 20432363 19539802 20512989 18210153 19519916 3084413 16681979 21159647 18971187 16779866 20935162 20524982 19919837 19052882 20084675 17138121 16830150 19208518 16540662 16328049 18056438 16502159 17162532 19171122 20101231 16288022 20514400 17173139 19383236 18506893 18785209 18393292 18691550 16569478 18788625 20727157 19107877 17978847 3581430 20214788 19394651 17761372 16698587 16935385 10672840 10737359 18978308 18665156 19418558 18494052 17055752 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
18.88 | 18059187 16023760 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
18.88 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
18.88 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
18.88 | 17173139 1701930 20007298 20935162 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
18.88 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
18.88 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
18.88 | 16507464 15276417 17306315 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.30 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.67 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.02 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.38 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
13.38 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
13.38 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
13.38 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
13.38 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.26 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.26 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.34 | 15792986 17519947 16455267 17924179 17928571 16731534 16242529 15505089 16952015 17308081 16278810 16651473 15811867 16269455 16612575 17351982 17007740 17382496 16364871 15476868 17131338 16109756 17329180 18627295 17974986 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.84 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.84 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.84 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
23.75 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
23.75 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
23.75 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
23.75 | 7505956 17174075 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
23.75 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
23.75 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.96 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.18 | 16154183 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.50 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.50 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.09 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.09 | 17681005 17333356 16919318 11677210 16105132 17110522 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.09 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.46 | 15894690 |
MESH:D016770 |
Ciliophora Infections |
|
Formaldehyde |
5.35 | 12113305 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.98 | 16354765 15668235 8697196 12621046 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.84 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
7.86 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
7.86 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
7.86 | 15741050 16640504 19440933 11134977 17148506 19056647 17191121 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
7.86 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.61 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
4.61 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
4.61 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.61 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.56 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.58 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.58 | 20055451 10048152 15322242 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.48 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Formaldehyde |
4.44 | 15932584 16958921 15059100 12081698 14996049 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.29 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.53 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
7.77 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
7.77 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.65 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.65 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.72 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
11.04 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.04 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
11.04 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.04 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.04 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.39 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.39 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.73 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.92 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
9.92 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.92 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.60 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.19 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.19 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.29 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.04 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.04 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.77 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.86 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.56 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.82 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.57 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.74 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.30 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.96 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.72 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.82 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.08 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.08 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 11564622 |
MESH:D005141 |
Eyelid Diseases |
|
Formaldehyde |
6.08 | 14996049 |
MESH:D005199 |
Fanconi Anemia |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
16.57 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
16.57 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
16.57 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.57 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.17 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.29 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.10 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
13.10 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.10 | 20067830 |
MESH:D005393 |
Fish Diseases |
|
Formaldehyde |
5.31 | 12113305 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.38 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.92 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
15.44 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
15.44 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
15.44 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
15.44 | 19804834 |
MESH:D005910 |
Glioma |
marker/mechanism |
|
| |
MESH:D005910 |
Glioma |
|
Quercetin |
2.94 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.29 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.33 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.93 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.93 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.28 | 18674790 16244372 16244371 17875725 17888722 16495754 16144979 18006777 12587719 16879835 14766674 16707910 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.45 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.45 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.64 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.38 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.13 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.07 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.71 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.71 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.71 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.89 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
15.61 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
15.61 | 18501091 15147373 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Nitrogen Mustard Compounds |
15.61 | 16794504 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
15.61 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.75 | 16354765 15340226 8697196 18606429 16959395 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.74 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
8.39 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
8.39 | 11834736 18262572 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.76 | 16873680 |
MESH:D006973 |
Hypertension |
|
Benzene |
11.43 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.43 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
11.43 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.43 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.05 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.52 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.36 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.19 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.99 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.99 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
10.72 | 18785209 |
MESH:D007249 |
Inflammation |
|
polyphenols |
10.72 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
10.72 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.72 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
10.19 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
10.19 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.67 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.67 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.67 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.14 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.08 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
13.08 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
13.08 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.08 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.89 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.50 | 12371664 |
MESH:D007938 |
Leukemia |
|
Benzene |
9.76 | 18335105 15935818 17119257 14694614 |
MESH:D007938 |
Leukemia |
|
Genistein |
9.76 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
9.76 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.86 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.06 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.65 | 19478238 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.39 | 16087638 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.74 | 16707609 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.10 | 18407596 18665156 19638242 18522880 20032147 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.10 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.31 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.31 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.31 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
6.31 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.31 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.16 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.16 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
6.16 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
27.88 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
27.88 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
27.88 | 19638242 20434301 19812893 21047994 12771043 20405173 15175105 20492335 19254457 19256749 19499222 2862719 20101389 20118626 18648771 20501860 20452335 20583210 12112319 19090486 21278145 19255062 18977376 19850985 19294768 10737359 20137499 19833225 18754104 19996281 19690152 19642983 18644402 15885732 19426721 9163691 16942905 2422723 19427195 21167192 19073162 19551842 18978307 21071580 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
27.88 | 21047994 8742319 15975961 19812893 19482888 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
27.88 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
27.88 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
27.88 | 20405173 19321006 19812893 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
27.88 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
27.88 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
25.45 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
25.45 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
25.45 | 2563599 18253720 17174075 18093689 17854601 19126423 9362446 18164116 3124819 18544905 18308698 18079962 16267830 18775883 21159647 16842330 18282651 19539802 19004024 19519916 19009564 17942915 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
25.45 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
25.45 | 2563599 17172636 6150874 18308698 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
25.45 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
25.45 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.98 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.51 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
12.29 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
12.29 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
12.29 | 20869020 17053015 20064080 18520028 6695378 20464547 18816296 20135361 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
12.29 | 21163286 6695378 20970405 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
12.29 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
12.29 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.29 | 17306315 16712894 17077188 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.29 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Benzene |
7.15 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.15 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
9.37 | 17088997 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
9.37 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.09 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.09 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.28 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
9.27 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
9.27 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
16.86 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
16.86 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
16.86 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
16.86 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
16.86 | 11606380 8985016 |
MESH:D008527 |
Medulloblastoma |
marker/mechanism |
|
| |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
6.89 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
6.89 | 16270382 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.89 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.89 | 19082730 16487513 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.94 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.11 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.49 | 16801185 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.59 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.23 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.04 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.04 | 16274795 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.49 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
6.94 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
6.94 | 16490592 17164350 17049120 16267019 17935668 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.57 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.22 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
16.56 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
16.56 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
16.56 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
16.56 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
16.56 | 17125593 16456233 16317513 17188708 16525036 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.24 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.24 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
12.95 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
12.95 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
12.95 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.46 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.18 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.48 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.48 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.16 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
14.16 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.16 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
14.16 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.16 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.27 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.27 | 20056578 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.48 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.14 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.48 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.48 | 16889571 15640375 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.66 | 17356569 18619942 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
8.67 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.67 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
6.90 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.90 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.11 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.73 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.73 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
9.79 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
9.79 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.82 | 20387270 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.38 | 16303764 |
MESH:D009669 |
Nose Neoplasms |
|
Formaldehyde |
5.05 | 4038687 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.74 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
3.93 | 15612468 16737584 15576619 17178637 17119257 15913788 15935809 17479406 15727169 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.07 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.07 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
15.32 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
15.32 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
15.32 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.88 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
marker/mechanism |
|
| 17688236 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
13.97 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
13.97 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
13.97 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
13.97 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.97 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
marker/mechanism |
|
| |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.48 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
11.48 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.48 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
11.48 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.41 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.87 | 16412576 19114014 18619942 19232380 15451049 16140633 11445065 18191903 11535288 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.82 | 15795934 15927086 15574749 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.95 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.86 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.86 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.28 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
19.85 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
19.85 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
19.85 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
19.85 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.28 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.61 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.61 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.85 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.85 | 16888761 16729912 15749863 16868541 15897917 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.85 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.85 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.85 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.85 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.85 | 16731767 17675339 15767336 17636462 17718901 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.85 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.85 | 18760546 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.02 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.20 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.12 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.93 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.28 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.08 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.08 | 17520802 17058453 16314181 16317513 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.56 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.18 | 16303925 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.73 | 18313854 15625365 17710206 17203757 15675481 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.96 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.49 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.25 | 16862918 |
MESH:D012595 |
Scleroderma, Systemic |
|
Formaldehyde |
5.59 | 14979077 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.50 | 11442880 4039156 3137016 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.53 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
20.65 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
20.65 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
20.65 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
20.65 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
20.65 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.65 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.28 | 16767912 15625365 17203757 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.64 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.57 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
3.24 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.24 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.24 | 18456281 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.22 | 16321402 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
5.33 | 16930453 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.95 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.35 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.91 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.66 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.60 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
10.73 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
10.73 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
10.73 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.96 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.56 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
14.56 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
14.56 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
14.56 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.56 | 17306315 16712894 11723127 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
20.63 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
indole-3-carbinol |
20.63 | 16082211 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
20.63 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
20.63 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
14.48 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
14.48 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
14.48 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.68 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.13 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.29 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.28 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
9.38 | 16364871 17334414 17678736 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.38 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.95 | 15886252 |
MESH:D009396 |
Wilms Tumor |
marker/mechanism |
|
| |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.14 | 17120751 |